Iatrogenic disease management: moderating medication errors and risks in a pharmacy benefit management environment

Area of Science:

• Health Services Research
• Pharmaceutical Policy
• Population Health Management

Background:

• Disease Management (DM) programs are crucial for managing chronic conditions, offering clinical and economic value.
• Existing DM programs face challenges in achieving anticipated cost containment.
• Medication errors are a significant and growing concern in US health policy, contributing to high healthcare costs.

Purpose of the Study:

• To explore the integration of Medication Error Risk Reduction strategies into existing Disease Management programs.
• To identify synergistic effects and potential cost containment benefits of combining these two healthcare program types.
• To address medication errors as a significant cost driver within population-based health initiatives.

Main Methods:

• This article presents a conceptual framework and discussion, not empirical data.
• It analyzes the potential for leveraging DM infrastructure to implement medication error reduction initiatives.
• The focus is on managed care environments and their existing program structures.

Main Results:

• Combining medication error reduction with DM programs presents a promising strategy for enhancing healthcare value.
• Synergistic effects can lead to improved clinical outcomes and greater cost containment than standalone programs.
• Addressing medication errors systematically within DM can mitigate significant cost drivers.

Conclusions:

• Disease Management programs are a viable platform for integrating medication error risk reduction strategies.
• This integration offers a pathway to achieve greater cost savings and improve the effectiveness of population health management.
• A proactive, organized approach to medication errors within DM is essential for optimizing healthcare delivery.